CAPTOPRIL IN THE TREATMENT OF HYPERTENSION

被引:14
作者
GAVRAS, H [1 ]
BRUNNER, HR [1 ]
GAVRAS, I [1 ]
机构
[1] BOSTON CITY HOSP, THORNDIKE MEM LAB, BOSTON, MA 02118 USA
关键词
D O I
10.7326/0003-4819-95-4-505
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:505 / 506
页数:2
相关论文
共 15 条
[1]  
BRUNNER HR, 1978, LANCET, V2, P704
[2]  
FERGUSON RK, 1977, LANCET, V1, P775
[3]   ANTIHYPERTENSIVE EFFECT OF ORAL ANGIOTENSIN CONVERTING-ENZYME INHIBITOR SQ 14225 IN MAN [J].
GAVRAS, H ;
BRUNNER, HR ;
TURINI, GA ;
KERSHAW, GR ;
TIFFT, CP ;
CUTTELOD, S ;
GAVRAS, I ;
VUKOVICH, RA ;
MCKINSTRY, DN .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (18) :991-995
[4]   FATAL PANCYTOPENIA ASSOCIATED WITH THE USE OF CAPTOPRIL [J].
GAVRAS, I ;
GRAFF, LG ;
ROSE, BD ;
MCKENNA, JM ;
BRUNNER, HR ;
GAVRAS, H .
ANNALS OF INTERNAL MEDICINE, 1981, 94 (01) :58-59
[5]  
HOORNTJE SJ, 1980, LANCET, V1, P1212
[6]   CAPTOPRIL COMPARED WITH OTHER ANTIRENNIN SYSTEM AGENTS IN HYPERTENSIVE PATIENTS - ITS TRIPHASIC EFFECTS ON BLOOD-PRESSURE AND ITS USE TO IDENTIFY AND TREAT THE RENIN FACTOR [J].
LARAGH, JH ;
CASE, DB ;
ATLAS, SA ;
SEALEY, JE .
HYPERTENSION, 1980, 2 (04) :586-593
[7]   EFFECT OF CAPTOPRIL ON RENAL VASCULAR TONE IN PATIENTS WITH ESSENTIAL-HYPERTENSION [J].
MIMRAN, A ;
BRUNNER, HR ;
TURINI, GA ;
WAEBER, B ;
BRUNNER, D .
CLINICAL SCIENCE, 1979, 57 :S421-S423
[8]  
MURTHY VS, 1978, CIRC RES, V43, pI40
[9]   DESIGN OF SPECIFIC INHIBITORS OF ANGIOTENSIN-CONVERTING ENZYME - NEW CLASS OF ORALLY ACTIVE ANTIHYPERTENSIVE AGENTS [J].
ONDETTI, MA ;
CUSHMAN, DW .
SCIENCE, 1977, 196 (4288) :441-444
[10]   GENETIC BASIS OF RHEUMATOID DISEASE - HLA ANTIGENS, DISEASE MANIFESTATIONS, AND TOXIC REACTIONS TO DRUGS [J].
PANAYI, GS ;
WOOLEY, P ;
BATCHELOR, JR .
BMJ-BRITISH MEDICAL JOURNAL, 1978, 2 (6148) :1326-1328